Table III.
Replication result of top SNPs associated with recurrence in NSCLC patients treated with surgery-only
SNP | MD Anderson | P | MOIa | Mayo Clinic recur (yes/no) | Mayo Clinic | P | Meta | Meta P | ||
---|---|---|---|---|---|---|---|---|---|---|
HRb (95% CI) | WW | WV | VV | HRb (95% CI) | HRb (95% CI) | |||||
rs2536182 | 0.47 (0.28–0.80) | 5.24×10 −3 | Dom | 12/67 | 9/146 | 5/57 | 0.39 (0.18–0.84) | 0.0162 | 0.44 (0.29–0.68) | 2.30×10 −4 |
rs10898563c | 2.98 (1.60–5.35) | 0.0004 | Rec | 12/11 | 100/129 | 3/38 | 0.81 (0.24–2.75) | 0.7409 | 2.31 (1.33–3.96) | 0.0246 |
Significant P values (P < 0.05) in bold type. VV, homozygous variant genotype;
WW, homozygous wild-type genotype; WV, heterozygous variant genotype.
aMOI: model of inheritance, the model with the smallest P value for both discovery and replication groups; Dom, dominant; Rec, recessive.
bAdjusted by age, sex, smoking status, cancer stage and treatment regimen.
cInformation for three samples from the Mayo Clinic was missing due to failed genotyping assay.